摘要 |
<p>The present invention relates to at least one vasodilating agent, such as glyceryl trinitrate, for acute prevention or treatment of patients suffering from somnolepsy, a new sleep disorder characterized by somnoleptic seizures and/or sleep attacks, and acute treatment of sleep attacks in other known sleep disorders. The vasodilating agent has an onset of action within 15 to 60 seconds after administration and may thus prevent sleep attacks when a forewarning of a sleep attack is experienced. The effect of the vasodilating agent may be prolonged by further administrate an immediate release formulation comprising a CNS-stimulant, such as methylphenidate.</p> |